What happened
President Donald Trump Monday signed an executive order aimed at persuading pharmaceutical companies to lower the prices of U.S. prescription drugs. Trump's order gives companies a 30-day deadline to start voluntarily lowering prices or face potential consequences.
Who said what
The White House "teased the announcement as seismic," but Trump's order lacks "teeth" and "cites no obvious legal authority to mandate lower prices," The New York Times said. It was "something of a win" for drugmakers, which had been "bracing" for a "much more damaging" policy. "Far from demonizing pharmaceutical companies for high prices," The Washington Post said, Trump "focused his fire" on European countries "for negotiating drug prices so low" the U.S. picks up the "costs of innovation."
Sen. Bernie Sanders (I-Vt.) said while he agreed with Trump that U.S. drug prices are "an outrage," the problem was not that prices are "too low in Europe and Canada" but that the "extraordinarily greedy pharmaceutical industry" is "ripping off the American people." Besides, he added, "as Trump well knows, his executive order will be thrown out by the courts."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
If drug companies do not lower their prices, Trump's order directs Health Secretary Robert F. Kennedy Jr. to develop a new rule that "ties the price the U.S. pays for medications to lower prices paid by other countries," said The Associated Press.
-
September 30 editorial cartoonsCartoons Tuesday's political cartoons include finger pointing, disunited nations, and Donald Trump's esprit de corps
-
What Saudi Arabia wants with EA video gamesIn the Spotlight The kingdom’s latest investment in gaming is another win for its ‘soft power’ portfolio
-
How the One Piece manga flag became a Gen Z resistance symbolThe Explainer Straw-hat skull seen at protests in Indonesia, Nepal and France shows how young people are ‘reshaping the vocabulary of dissent’
-
Private equity firms might be causing more deaths in hospital ERsThe Explainer Deaths in ERs purchased by private equity firms rose 13%
-
Why are autism rates increasing?The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
The UK’s opioid crisis: why the stats don’t add upThe Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
-
Quit-smoking ads are being put outUnder the radar The dissolution of a government-funded campaign could lead to more smokers in the future
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
The truth about sunscreenThe Explainer The science behind influencer claims that sun cream is toxic
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
